`DISTRICT OF MINNESOTA
`
`Case No. 17‐CV‐1969 (PJS/TNL)
`
`ORDER
`
`QXMÉDICAL, LLC,
`
`
`Plaintiff,
`
`v.
`
`VASCULAR SOLUTIONS, LLC; TELEFLEX
`INNOVATIONS S.À.R.L.; and ARROW
`INTERNATIONAL, INC.,
`
`Defendants.
`
`Courtland C. Merrill and Philip J. Kaplan, ANTHONY OSTLUND BAER
`& LOUWAGIE P.A., for plaintiff.
`
`J. Thomas Vitt, Emily Justine Tait, Patrick J. O’Rear, and Sanjiv Prakash
`Laud, JONES DAY; Kenneth E. Levitt, DORSEY & WHITNEY, for
`defendants.
`
`Plaintiff QXMédical, LLC (“QXMédical”) filed this action in June 2017, seeking a
`
`declaration that its Boosting Catheter does not infringe any of defendants’ (collectively
`
`“Teleflex’s”) patents and that Teleflex’s patents are invalid. Teleflex counterclaimed for
`
`infringement, asserting claims in six patents. The Court issued an order construing
`
`certain terms of the patents in October 2018 and an order on the parties’ motions for
`
`summary judgment in October 2019. ECF Nos. 102, 156. Trial is scheduled to begin on
`
`February 24, 2020.
`
`IPR2020-00131
`Medtronic v. Teleflex
`Medtronic Exhibit 1894 - Page 1
`
`
`
`In July 2019, Teleflex and related parties brought an infringement action against
`
`Medtronic, Inc. and related parties (collectively “Medtronic”), asserting many of the
`
`same patent claims at issue in this case. See Vascular Solutions LLC v. Medtronic, Inc.,
`
`No. 19‐CV‐1760 (PJS/TNL). Between November 12 and 14, 2019, Medtronic filed 13
`
`petitions for inter partes review of a number of Teleflex’s patent claims, including all but
`
`two of the claims at issue in this case. A decision on whether to institute review is due
`
`in mid‐May 2020. See 35 U.S.C. § 314(b); 37 C.F.R. § 42.107(b).
`
`In light of the pendency of Medtronic’s petitions, QXMédical seeks a stay of this
`
`action. QXMédical states that, if the Court grants a stay, it will suspend domestic sales
`
`of its Boosting Catheter during the pendency of the stay and waive two of its remaining
`
`invalidity defenses (obviousness and anticipation1), thus simplifying the trial. Given
`
`these concessions, the Court finds that a stay until such time as the Patent Trial and
`
`Appeal Board decides whether to institute review on Medtronic’s petitions is
`
`warranted. The Court will therefore reschedule the trial for June 22, 2019. A formal
`
`trial notice setting forth all deadlines will follow. If the Patent Trial and Appeal Board
`
`decides to institute review, the Court will invite the parties to brief whether the stay
`
`should extend through the conclusion of the review process.
`
`1QXMédical’s remaining anticipation defense relates to claim 1 of the RE45,380
`patent; QXMédical retains its right to appeal the Court’s rejection, at summary
`judgment, of its anticipation defense relating to claim 53 of the RE46,116 patent.
`
`-2-
`
`IPR2020-00131
`Medtronic v. Teleflex
`Medtronic Exhibit 1894 - Page 2
`
`
`
`ORDER
`
`Based on the foregoing, and on all of the files, records, and proceedings herein,
`
`IT IS HEREBY ORDERED THAT:
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`Plaintiff’s motion to stay [ECF No. 173] is GRANTED in part.
`
`This case is STAYED until such time as the Patent Trial and Review Board
`
`issues a decision on whether to institute review in response to any of the
`
`petitions filed by Medtronic, Inc., that seek review of patent claims
`
`involved in this case.
`
`The parties must notify the Court of the Patent Trial and Review Board’s
`
`decision as soon as reasonably possible after it is rendered.
`
`Until further order of the Court, plaintiff is enjoined from selling its
`
`infringing Boosting Catheter product in the United States.
`
`Plaintiff’s remaining defenses of obviousness and anticipation are waived.
`
`Trial in this matter is scheduled to begin on June 22, 2019.
`
`Dated: December 26, 2019
`
`s/Patrick J. Schiltz
`Patrick J. Schiltz
`United States District Judge
`
`-3-
`
`IPR2020-00131
`Medtronic v. Teleflex
`Medtronic Exhibit 1894 - Page 3
`
`